Biomerica, Inc. (BMRA)
BMRA Price and Sentiment
BMRA Latest news
Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment2021-11-04 06:39
IRVINE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA) today announced that the Canadian Patent Office has issued a notice of allowance for Biomerica's patent application pertaining to the Company's InFoods® diagnostic guided therapy platform technology that offers a novel approach in the treatment of patients suffering from Irritable Bowel Syndrome (“IBS”). IBS is a chronic, often debilitating, functional gastrointestinal (“GI”) disorder with symptoms that include abdominal pain, bloating, and altered bowel behaviors, such as constipation and/or diarrhea, or alternating between the two.
IRVINE, Calif. , Oct. 29, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that in conjunction with Breast Cancer Awareness month, which takes place each October, it has launched its new website for the Aware® at-home breast self-exam pad. Breast cancer is the most commonly-diagnosed cancer in women. In 2021, an estimated 281,550 new cases of invasive breast cancer will be diagnosed and approximately 43,600 women will die from breast cancer in US. One in eight women will develop invasive breast cancer in their lifetime.
Biomerica(NASDAQ:BMRA) stock rose by 2.53% on Monday after the company reported its Q1 earnings results on Friday, October 15, 2021 at 06:30 AM. Here's what investors need to know about the announcement.
IRVINE, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) today announced that Walmart has begun in-store sales and rollout of the Company's EZ Detect™ colorectal disease screening test within the nationwide Walmart retail system. Biomerica has shipped the EZ Detect product to Walmart distribution centers in the US and product is projected to be on the shelf in over 4,600 Walmart Stores nationwide over the next two weeks. The in-store retail placement follows Biomerica's previous announcement in early October, that Walmart had begun sales of EZ Detect™ product for online purchase through Walmart.com (https://www.walmart.com/ip/EZ-Detect-Colon-Disease-Test-Kit/577079744). As part of its ongoing sales strategy, the Company has hired an internal digital and social media team to increase its presence on all major social communication platforms (Instagram: https://bit.ly/3j5FYDB; Facebook: https://bit.ly/3aBJBfN; Twitter: https://bit.ly/3BNROJW), and to promote awareness fo
IRVINE, Calif., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products, today reported its first quarter fiscal 2022 financial results.
The stock price of Biomerica, Inc. (NASDAQ: BMRA) increased by over 19% during intraday trading today. This is why it happened.
According to Fintel, here are five short squeeze stocks that are among the most likely to see a squeeze attempt moving forward. The post Short Squeeze Stocks: BMRA, PROG and 3 Other Stocks Experts Think Are Ready to Pop appeared first on InvestorPlace.
5 Short Squeeze Candidates To Watch: Aterian, Marin On List Again, Plus 3 New Small-Cap Medical Plays2021-10-04 10:31
Potential short squeeze plays have gained steam in 2021 with new retail traders looking for the next GameStop Corp (NYSE: GME) and AMC Entertainment Holdings Inc (NYSE: AMC), two stocks that attracted strong interest and saw shares spike. A short squeeze can occur when a heavily shorted stock rises in value instead of falling.
The stock price of Biomerica, Inc. (NASDAQ: BMRA) increased by 38% in the previous trading session. This is why it happened.
Biomerica (BMRA) stock is surging higher on Friday thanks to a new deal with Walmart (WMT) concerning its EZ Detect product. The post BMRA Stock: The Big Walmart Deal That Has Biomerica Investors Smiling Today appeared first on InvestorPlace.